• / Free eNewsletters & Magazine
  • / My Account
Home>Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress

Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress

3party Content

Wed, 17 Sep 2014

Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.